Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Acta Haematologica|October 30, 2003
Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's diseaseM Helen Huls, Cliona M Rooney, Helen E HeslopLeukemia & Lymphoma|June 7, 2006
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantationCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapyUluhan Sili, M Helen Huls, Alan R Davis, et al.Transplantation|September 17, 2004
Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytesSamart Pakakasama, Gretchen M Eames, Michael C Morriss, et al.Blood|November 2, 2002
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignanciesStephen Gottschalk, Oliver L Edwards, Uluhan Sili, et al.Journal of Visualized Experiments : Jove|October 21, 2015
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture SystemPappanaicken Kumaresan, Mathew Figliola, Judy S Moyes, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphomaKarin C Straathof, Ann M Leen, Elizabeth L Buza, et al.Cancer Gene Therapy|December 20, 2003
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cellsHans-Joachim Wagner, Catherine M Bollard, Stéphane Vigouroux, et al.Blood|April 20, 2002
Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunityCatherine M Bollard, Claudia Rössig, M Julia Calonge, et al.Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.Pageof 3